Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer

被引：0
|
作者：
Se Hoon Park
Soo-Mee Bang
Eun Kyung Cho
Dong Bok Shin
Jae Hoon Lee
Woon KI Lee
Min Chung
机构：
[1] Gachon Medical School Gil Medical Center,Division of Hematology and Oncology, Department of Internal Medicine
[2] Gachon Medical School Gil Medical Center,Department of General Surgery
来源：
BMC Cancer | / 5卷
关键词：
Gastric Cancer; Docetaxel; Dose Level; Febrile Neutropenia; Dose Escalation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer
    Park, SH
    Bang, SM
    Cho, EK
    Shin, DB
    Lee, JH
    Lee, WKI
    Chung, M
    BMC CANCER, 2005, 5 (1)
  • [2] Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer
    Biyun Wang
    Wen Zhang
    Xiaonan Hong
    Ye Guo
    Jin Li
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 213 - 218
  • [3] Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer
    Wang, Biyun
    Zhang, Wen
    Hong, Xiaonan
    Guo, Ye
    Li, Jin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 213 - 218
  • [4] A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer
    M Ando
    T Watanabe
    Y Sasaki
    D-F Ying
    Y Omuro
    N Katsumata
    M Narabayashi
    Y Tokue
    H Fujii
    T Igarashi
    H Wakita
    T Ohtsu
    K Itoh
    I Adachi
    T Taguchi
    British Journal of Cancer, 1998, 77 : 1937 - 1943
  • [5] A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer
    Ando, M
    Watanabe, T
    Sasaki, Y
    Ying, DF
    Omuro, Y
    Katsumata, N
    Narabayashi, M
    Tokue, Y
    Fujii, H
    Igarashi, T
    Wakita, H
    Ohtsu, T
    Itoh, K
    Adachi, I
    Taguchi, T
    BRITISH JOURNAL OF CANCER, 1998, 77 (11) : 1937 - 1943
  • [6] 5-DAY CONTINUOUS INFUSION OF 5-FLUOROURACIL FOR ADVANCED COLORECTAL, GASTRIC, AND PANCREATIC ADENOCARCINOMA
    HARTMAN, HA
    KESSINGER, A
    LEMON, HM
    FOLEY, JF
    JOURNAL OF SURGICAL ONCOLOGY, 1979, 11 (03) : 227 - 238
  • [7] Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma
    Ueno, H
    Okada, S
    Okusaka, T
    Ikeda, M
    Kuriyama, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (02) : 155 - 160
  • [8] Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma
    Hideki Ueno
    Shuichi Okada
    Takuji Okusaka
    Masafumi Ikeda
    Hitoshi Kuriyama
    Cancer Chemotherapy and Pharmacology, 2002, 49 : 155 - 160
  • [9] COMBINATION CHEMOTHERAPY WITH CISPLATIN AND 5-FLUOROURACIL 5-DAY INFUSION IN THE THERAPY OF ADVANCED GASTRIC-CANCER - A PHASE-II TRIAL
    LACAVE, AJ
    BARON, FJ
    ANTON, LM
    ESTRADA, E
    DESANDE, LMG
    PALACIO, I
    ESTEBAN, E
    GRACIA, JM
    BUESA, JM
    FERNANDEZ, OA
    BARON, MG
    ANNALS OF ONCOLOGY, 1991, 2 (10) : 751 - 754
  • [10] Phase I/II docetaxel, oxaliplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
    Kim, Sung Rok
    Park, Sung-En
    Yuh, Young Jin
    Sohn, Byeong Seok
    Lee, Hye Ran
    Song, Hong-Suk
    Lee, Kyung-Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345